This study is the first evidence based work evaluated the systemic use of glucosamine as an
adjunctive therapy to closed mechanical debridement in chronic periodontitis. The use of
glucosamine sulphate was correlated with clinical outcomes and IL1-β level in the GCF of
patients with moderate to advanced chronic periodontitis